Dr. Michael Scott Krathen, MD

Dr. Krathen practices at Essential Dermatology in Natick, Massachusetts.

Dr. Krathen's NPI, 1932376050, was assigned on May 8, 2008. Dr. Krathen graduated from Perelman School of Med at the University of Pennsylvania in 2007. Dr. Krathen holds Massachusetts license 242501.

Dr. Krathen's primary practice is Essential Dermatology, at 220 N Main St Suite 201 Suite 201, Natick, MA 01760-1100. The practice phone is (508) 827-2615.

Dr. Krathen's primary practice is Essential Dermatology in Natick, Massachusetts. Dr. Krathen is also affiliated with Newton-Wellesley Hospital. The medical group on file is Essential Dermatology. Dmand AI also links Dr. Krathen to 1 more physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Krathen practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Krathen's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Krathen is licensed in Massachusetts.

CMS data shows 2,120 Medicare services from Dr. Krathen across 18 procedure codes in 2024, for 731 Medicare patients. Medicare paid $123,815 for them. Every service was in an office.

CMS counts 731 Medicare patients who saw Dr. Krathen in 2024. The largest group is 65 to 74, with 334 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Krathen's median patient age at 58, with 40% women.

In 2024, Dr. Krathen wrote 1,028 Medicare Part D claims for 371 patients. 89% of them were for generic drugs. CMS names the drug for 895 of them, across 28 drugs with 11 or more claims each, at $222,807 in total drug cost. In 2023, CMS named 763 claims across 27 drugs.

Dr. Krathen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 411 procedures of removal of skin lesions by Dr. Krathen, more than 85% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Krathen, published from 2007 to 2015. 2010 was the busiest year, with 2. The most frequent topics are Skin Neoplasms, Diagnosis, Differential and Lupus Erythematosus, Cutaneous. Dr. Krathen has published most often in Dermatol Online J. Dr. Krathen's most frequent co-authors are Sumaira Zareen Aasi, MD, Farah Rukhsana Abdulla, MD and Joerg Albrecht, MD.

Dmand AI links Dr. Krathen to 1 clinical trial. Conditions studied include Lymphoma, Large-Cell, Anaplastic and Lymphoma, T-Cell, Cutaneous. Open Payments lists research payments to Dr. Krathen that name 1 trial.

CMS Open Payments shows 70 general payments to Dr. Krathen from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 68% of the total. Lumenis, Inc paid the most, $500. It also lists 4 research payments totaling $6,549 from 2016 to 2018, naming 1 clinical trial.

Dr. Krathen graduated from Perelman School of Med at the University of Pennsylvania in 2007.